![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR
Department of Pathology, St. Louis University School of Medicine, St. Louis, Missouri
We have previously demonstrated that thrombin stimulation of endothelial cells results in increased membrane-associated, Ca2+-independent phospholipase A2 (iPLA2) activity, accelerated hydrolysis of membrane plasmalogen phospholipids, and production of several biologically active phospholipid metabolites, including prostacyclin and platelet-activating factor (PAF) that is abolished by pretreatment with the iPLA2-selective inhibitor bromoenol lactone. This study was designed to further investigate the role of alternative PLA2 inhibitors, including methyl arachidonyl fluorophosphonate (MAFP, an inhibitor of cytosolic PLA2 isoforms), on phospholipid turnover and PAF production from thrombin-stimulated human coronary artery endothelial cells (HCAECs). Paradoxically, pretreatment of HCAEC with MAFP (525 µM) resulted in a significant increase in PAF production in both unstimulated and thrombin-stimulated cells that was found to be a direct result of inhibition of PAF acetylhydrolase (PAF-AH) activity. Pretreatment with MAFP did not significantly inhibit HCAEC PLA2 activity, possibly due to the localization of PLA2 activity in the membrane fraction rather than the cytosol. Bromoenol lactone did not inhibit PAF-AH activity, even at concentrations as high as 20 µM. We conclude that MAFP augments thrombin-stimulated PAF production by inhibition of PAF catabolism without affecting membrane-associated iPLA2 activity.
Address correspondence to: Dr. Jane McHowat, Department of Pathology, St. Louis University School of Medicine, 1402 S. Grand Blvd., St. Louis, MO 63104. E-mail: mchowatj{at}slucare1.sluh.edu
This article has been cited by other articles:
![]() |
J. Chen, L. Yang, J. M. Foulks, A. S. Weyrich, G. K. Marathe, and T. M. McIntyre Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis J. Lipid Res., November 1, 2007; 48(11): 2365 - 2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Kinsey, J. McHowat, C. S. Beckett, and R. G. Schnellmann Identification of calcium-independent phospholipase A2{gamma} in mitochondria and its role in mitochondrial oxidative stress Am J Physiol Renal Physiol, February 1, 2007; 292(2): F853 - F860. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kriska, G. K. Marathe, J. C. Schmidt, T. M. McIntyre, and A. W. Girotti Phospholipase Action of Platelet-activating Factor Acetylhydrolase, but Not Paraoxonase-1, on Long Fatty Acyl Chain Phospholipid Hydroperoxides J. Biol. Chem., January 5, 2007; 282(1): 100 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Meyer and J. McHowat Calcium-independent phospholipase A2-catalyzed plasmalogen hydrolysis in hypoxic human coronary artery endothelial cells Am J Physiol Cell Physiol, January 1, 2007; 292(1): C251 - C258. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. A. Kessen, R. H. Schaloske, D. L. Stephens, K. Killermann Lucas, and E. A. Dennis PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS J. Lipid Res., November 1, 2005; 46(11): 2488 - 2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Vinson, A. Rickard, J. S. Ryerse, and J. McHowat Neutrophil Adherence to Bladder Microvascular Endothelial Cells following Platelet-Activating Factor Acetylhydrolase Inhibition J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1241 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rickard, C. Portell, P. J. Kell, S. M. Vinson, and J. McHowat Protease-activated receptor stimulation activates a Ca2+-independent phospholipase A2 in bladder microvascular endothelial cells Am J Physiol Renal Physiol, April 1, 2005; 288(4): F714 - F721. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Meyer, P. J. Kell, M. H. Creer, and J. McHowat Calcium-independent phospholipase A2 is regulated by a novel protein kinase C in human coronary artery endothelial cells Am J Physiol Cell Physiol, February 1, 2005; 288(2): C475 - C482. [Abstract] [Full Text] [PDF] |
||||